Chronic hepatitis C: Treat or wait? Medical decision making in clinical practice

Por Niederau, Claus, Hüppe, Dietrich, Zehnter, Elmar, Möller, Bernd, Heyne, Renate, Christensen, Stefan, Pfaff, Rainer, Theilmeier, Arno, Alshuth, Ulrich, Mauss, Stefan
Publicado em 2012

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

Por Roeder, Claudia, Jordan, Sabine, Schulze zur Wiesch, Julian, Pfeiffer-Vornkahl, Heike, Hueppe, Dietrich, Mauss, Stefan, Zehnter, Elmar, Stoll, Sabine, Alshuth, Ulrich, Lohse, Ansgar W, Lueth, Stefan
Publicado em 2014

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

Por Hofmann, Wolf Peter, Mauss, Stefan, Lutz, Thomas, Schober, Andreas, Böker, Klaus, Moog, Gero, Baumgarten, Axel, Pfeiffer-Vornkahl, Heike, Alshuth, Ulrich, Hüppe, Dietrich, Wedemeyer, Heiner, Manns, Michael P., Schott, Eckart
Publicado no PLoS One (2015)

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3

Por Niederau, Claus, Mauss, Stefan, Schober, Andreas, Stoehr, Albrecht, Zimmermann, Tim, Waizmann, Michael, Moog, Gero, Pape, Stefan, Weber, Bernd, Isernhagen, Konrad, Sandow, Petra, Bokemeyer, Bernd, Alshuth, Ulrich, Steffens, Hermann, Hüppe, Dietrich
Publicado em 2014

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

Por Marcellin, Patrick, Xie, Qing, Woon Paik, Seung, Flisiak, Robert, Piratvisuth, Teerha, Petersen, Jörg, Asselah, Tarik, Cornberg, Markus, Ouzan, Denis, Foster, Graham R., Papatheodoridis, Georgios, Messinger, Diethelm, Regep, Loredana, Bakalos, Georgios, Alshuth, Ulrich, Lampertico, Pietro, Wedemeyer, Heiner
Publicado no PLoS One (2020)